Société Annexin Pharmaceuticals AB (publ) Nasdaq Stockholm
Actions
ANNX BTA
SE0013748894
Recherche biotechnologique et médicale
Temps Différé
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
- SEK | -.--% | -3,17% | -.--% |
Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Anna Frostegård
FOU | Founder | 51 | 01/01/14 |
Chief Executive Officer | 63 | 01/01/18 | |
Director of Finance/CFO | 53 | 11/04/23 | |
Susan Suchdev
COO | Chief Operating Officer | 52 | - |
Alain Thibault
PRN | Corporate Officer/Principal | - | 18/01/23 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Uli Alf Hacksell
CHM | Chairman | 74 | 01/01/21 |
Mårten Österlund
BRD | Director/Board Member | 67 | 01/01/21 |
Chief Executive Officer | 63 | 01/01/18 | |
Director/Board Member | 48 | 01/01/17 | |
Director/Board Member | 65 | 01/01/16 | |
Director/Board Member | 66 | 01/01/17 | |
Director/Board Member | 71 | - | |
Anthon Jahreskog
BRD | Director/Board Member | 44 | 01/01/22 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 526 807 199 | 256 124 467 ( 48,62 %) | 0 | 48,62 % |
Coordonnées société
Secteur
Chiffre d''affaires - Taux de surprise
Varia. 1 janv. | Capi. | |
---|---|---|
+15,55% | 121 Md | |
+12,66% | 107 Md | |
-2,53% | 24,82 Md | |
+1,11% | 22,48 Md | |
-9,58% | 18,32 Md | |
-42,28% | 16,33 Md | |
-18,92% | 15,31 Md | |
+6,19% | 14,08 Md | |
+28,83% | 11,74 Md |
- Bourse
- Actions
- Action ANNX
- Action ANNX BTA
- Société Annexin Pharmaceuticals AB (publ)